News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,022 Results
Type
Article (8020)
Company Profile (142)
Press Release (478129)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166739)
Career Advice (302)
Deals (25738)
Drug Delivery (7)
Drug Development (52872)
Employer Resources (14)
FDA (9761)
Job Trends (8567)
News (238200)
Policy (17892)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (490)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33156)
ALS (113)
Alzheimer's disease (988)
Antibody-drug conjugate (ADC) (286)
Approvals (10423)
Artificial intelligence (341)
ASCO (159)
Autoimmune disease (224)
Automation (29)
Bankruptcy (263)
Belgium (2)
Best Places to Work (6958)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (116)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3790)
Cardiovascular disease (227)
Career advice (245)
Career pathing (1)
CAR-T (180)
CDC (1)
CDMO (20)
Celiac Disease (1)
Cell therapy (493)
Cervical cancer (35)
Clinical research (48096)
Collaboration (1291)
Commercialization (3)
Compensation (1539)
Complete response letters (34)
COVID-19 (766)
CRISPR (64)
C-suite (811)
Cystic fibrosis (87)
Data (5913)
Denatured (4)
Depression (107)
Dermatology (71)
Diabetes (362)
Diagnostics (4227)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (167)
Earnings (73755)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88178)
Executive appointments (716)
FDA (12529)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (958)
Gene editing (126)
Generative AI (11)
Gene therapy (336)
GLP-1 (296)
Government (949)
Grass and pollen (2)
Guidances (281)
Healthcare (9368)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (164)
Infectious disease (958)
Inflammatory bowel disease (130)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (265)
Interviews (41)
IPO (12389)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (17)
Kidney disease (46)
Layoffs (59)
Legal (5195)
Licensing (20)
Liver cancer (45)
Longevity (20)
Lung cancer (549)
Lymphoma (259)
Machine learning (29)
Management (3)
Manufacturing (582)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8686)
Medtech (8846)
Mergers & acquisitions (14415)
Metabolic disorders (736)
mRNA (65)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1884)
NextGen: Class of 2026 (3150)
Non-profit (843)
Obesity (234)
Opinion (10)
Ovarian cancer (163)
Pain (179)
Pancreatic cancer (207)
Parkinson's disease (207)
Partnered (12)
Patents (505)
Patient recruitment (535)
Patient selection (4)
Peanut (32)
People (41383)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15525)
Phase 2 (21478)
Phase 3 (14491)
Pipeline (7816)
Policy (18)
Postmarket research (1570)
Preclinical (6558)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (593)
Real estate (3024)
Recruiting (6)
Regenerative medicine (5)
Regulatory (15008)
Reports (23)
Research institute (585)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (165)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (337)
Venture capital (17)
Weight loss (75)
Women's health (90)
Date
Last 7 days (293)
Last 30 days (1417)
Last 365 days (19029)
2026 (13913)
2025 (19251)
2024 (22974)
2023 (26538)
2022 (34591)
2021 (37151)
2020 (33471)
2019 (23256)
2018 (17469)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18127)
2012 (20222)
2011 (20426)
2010 (20332)
Location
Africa (229)
Alabama (80)
Alaska (2)
Arizona (312)
Arkansas (11)
Asia (17980)
Australia (2110)
California (12424)
Canada (3260)
China (552)
Colorado (504)
Connecticut (428)
Delaware (216)
Europe (24705)
Florida (1870)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (734)
India (53)
Indiana (326)
Iowa (16)
Japan (431)
Kansas (104)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1236)
Massachusetts (8136)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2718)
New Mexico (12)
New York (2915)
North Carolina (1322)
North Dakota (4)
Northern California (6245)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2310)
Puerto Rico (23)
Rhode Island (30)
South America (406)
South Carolina (78)
South Dakota (1)
Southern California (5180)
Tennessee (125)
Texas (2029)
United States (40276)
Utah (377)
Vermont (1)
Virginia (159)
Washington D.C. (39)
Washington State (960)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
486,022 Results for "oragenics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Oragenics Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update
August 30, 2026
·
4 min read
Press Releases
Oragenics Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum
September 16, 2026
·
5 min read
Press Releases
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
March 26, 2026
·
4 min read
Press Releases
Oragenics Achieves Full Activation of Australian Phase IIa Trial Network — All Three Sites Now Enrolling
July 7, 2026
·
4 min read
Press Releases
Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21
May 19, 2026
·
4 min read
Press Releases
ORAGENICS FILES ANNUAL REPORT ON FORM 10-K
March 17, 2026
·
6 min read
Press Releases
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION
March 13, 2026
·
5 min read
Press Releases
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
May 7, 2026
·
7 min read
Press Releases
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
May 5, 2026
·
6 min read
Press Releases
Oragenics Doses First Patient in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
April 14, 2026
·
8 min read
1 of 48,603
Next
